Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Transcatheter mitral valve repair (TMVr) is associated with “promising” short-term outcomes among patients with a history of cancer, according to new research published in the American Journal of Cardiology.

'Promising' new data on TMVr among cancer patients

The study's authors examined data from nearly 23,000 patients who underwent transcatheter mitral valve repair from 2014 to 2018. 

Thumbnail

TAVR vs. surgery among children and young adults with congenital heart disease

Though TAVR was once never considered a treatment option for younger patients, it is becoming more common as time goes on. 

Medtronic is once again recalling its HeartWare Ventricular Assist Device (HVAD) pump implant kit, a part of the company’s HeartWare HVAD system. This is a Class I recall, which means using the device can lead to serious injury or death. The new recall includes more than 1,600 devices distributed from October 2006 to June 2021.

FDA announces another recall of Medtronic HVAD pump implant kits—1 patient death reported

The recall includes more than 1,600 devices distributed from October 2006 to June 2021. Medtronic's HVAD system has already been associated with multiple issues, including a separate recall in 2021. 

Novavax NVX-CoV2373 COVID-19 vaccine myocarditis

FDA committee backs Novavax's COVID-19 vaccine despite heart damage concerns

The committee's approval comes days after the FDA shared details on a small number of trial participants who developed myocarditis or pericarditis after receiving the vaccine.  

Risk of dementia skyrockets when patients have more than 1 cardiovascular condition

“Many studies look at the risk of a single condition in relation to dementia, but health is more complex than that,” one researcher said.

Thumbnail

NIH grants $3.5 million toward researching COVID's neurological impact

The funds will be allocated specifically toward neuroimaging and cognitive and immunological tests to explore if and how mild and asymptomatic SARS-CoV-2 infections have a long-lasting impact on neurocognitive function. 

Charles D. Fraser, Jr., MD, executive director of the new Institute for Cardiovascular Health, a collaboration between Ascension Texas and the University of Texas at Austin, including its Dell Medical School. This new, state-of-the-art cardiology program fully integrates all the cardiac subspecialties to create a comprehensive heart team approach in treating patients.

VIDEO: Creating an integrated heart team program in central Texas

Charles D. Fraser, Jr., MD, executive director of the new Institute for Cardiovascular Health in Austin, Texas, discusses the facility's new, state-of-the-art cardiology program.

Links to all the SCAI 2022 late-breaking clinical research

The Society for Cardiovascular Angiography and Interventions (SCAI) has announced its late-breaking study presentations at its 2022 Scientific Sessions.